Publications

Do patients with fibromyalgia syndrome and healthy people differ in their opinions on placebo effects in routine medical care? | Pain Practice, 25, e70000 - 10.1111/papr.70000.

Van Lennep, J.P.A., Meijer, S., Karacaoglu, M., Rippe, R., Peerdeman, K.J., Van Middendorp, H., & Evers, A.W.M.

Go to publication  

Efficacy of open-label counterconditioning for reducing nocebo effects on pressure pain | European Journal of Pain - 10.1002/ejp.2112.

Meijer, S., Karacaoglu, M., van Middendorp, H., Veldhuijzen, D.S., Jensen, K.B., Peerdeman, K.J., & Evers, A.W.M. (2023)

Go to publication  

Susceptibility to Nocebo Hyperalgesia, Dispositional Optimism, and Trait Anxiety as Predictors of Nocebo Hyperalgesia Reduction. | The Clinical Journal of Pain - 10.1097/AJP.0000000000001112.

Karacaoglu, M., Meijer, S., Peerdeman, K.J., Dusseldorp, E., Jensen, K.B., Veldhuijzen, D.S., van Middendorp, H., Evers, A.W.M. (2023)

Go to publication  

Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design. | Frontiers in Psychology, 13, 1-11. - doi: 10.3389/fpsyg.2022.806409.

Meijer, S., van Middendorp, H., Peerdeman K.J. & Evers A.W.M. (2022).

Go to publication